OTX-14-007: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis

NCT02445326 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Allergic Conjunctivitis

Interventions

DRUG: Dexamethasone
OTHER: Placebo Vehicle

Sponsor

Ocular Therapeutix, Inc.

Collaborators

[object Object]